_id
69104e05ccc777a4e85d5317
Ticker
CHMMF
Name
Chimeric Therapeutics Limited
Exchange
PINK
Address
62 Lygon Street, Carlton, VIC, Australia, 3053
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.chimerictherapeutics.com
Description
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia.
Last Close
0.001
Volume
30000
Current Price
0.001
Change
0
Last Updated
2026-01-02T11:20:45.374Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
3642136
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
7130450
Cost Of Revenue
846763
Gross Profit
6283687
Operating Expenses
13779683
Operating Income
-7495996
Interest Expense
103589
Pretax Income
-7599585
Net Income
-7572537
Eps
-0.004457454692565163
Dividends Per Share
-
Shares Outstanding
3642136232
Income Tax Expense
27048
EBITDA
-3281523
Operating Margin
-105.12654881529215
Total Other Income Expense Net
-103589
Cash
5757474
Short Term Investments
-
Receivables
4551105
Inventories
-
Total Current Assets
10526412
Property Plant Equipment
-
Total Assets
21571171
Payables
6566448
Short Term Debt
-
Long Term Debt
-
Total Liabilities
19596657
Equity
1974514
Bs_currency_symbol
AUD
Depreciation
545281
Change In Working Capital
-214176
Cash From Operations
-4626545
Capital Expenditures
0
Cash From Investing
-25945
Cash From Financing
5456703
Net Change In Cash
-5068021
Cf_currency_symbol
-
PE
-
PB
0.8603878108739669
ROE
-383.5139685006032
ROA
-35.10489532533955
FCF
-4626545
Fcf Percent
-0.648843340883114
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
4.5
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
3.5
Net Net Investing Score
4
Quality Investing Score
1
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
7130450
Quarters > 0 > income Statement > cost Of Revenue
846763
Quarters > 0 > income Statement > gross Profit
6283687
Quarters > 0 > income Statement > operating Expenses
13779683
Quarters > 0 > income Statement > operating Income
-7495996
Quarters > 0 > income Statement > interest Expense
103589
Quarters > 0 > income Statement > pretax Income
-7599585
Quarters > 0 > income Statement > net Income
-7572537
Quarters > 0 > income Statement > eps
-0.004457454692565163
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1698847778
Quarters > 0 > income Statement > income Tax Expense
27048
Quarters > 0 > income Statement > EBITDA
-3281523
Quarters > 0 > income Statement > operating Margin
-105.12654881529215
Quarters > 0 > income Statement > total Other Income Expense Net
-103589
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
5757474
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
4551105
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
10526412
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
21571171
Quarters > 0 > balance Sheet > payables
6566448
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
19596657
Quarters > 0 > balance Sheet > equity
1974514
Quarters > 0 > balance Sheet > currency_symbol
AUD
Quarters > 0 > cash Flow > net Income
-7572537
Quarters > 0 > cash Flow > depreciation
545281
Quarters > 0 > cash Flow > change In Working Capital
-214176
Quarters > 0 > cash Flow > cash From Operations
-4626545
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-25945
Quarters > 0 > cash Flow > cash From Financing
5456703
Quarters > 0 > cash Flow > net Change In Cash
-5068021
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.004457454692565163
Quarters > 0 > ratios > PB
0.8603878108739669
Quarters > 0 > ratios > ROE
-383.5139685006032
Quarters > 0 > ratios > ROA
-35.10489532533955
Quarters > 0 > ratios > FCF
-4626545
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.648843340883114
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
5554094
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
5554094
Quarters > 1 > income Statement > operating Expenses
8214690
Quarters > 1 > income Statement > operating Income
-2660596
Quarters > 1 > income Statement > interest Expense
59434
Quarters > 1 > income Statement > pretax Income
-2720030
Quarters > 1 > income Statement > net Income
-2857887
Quarters > 1 > income Statement > eps
-0.002843667015595155
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1005000580
Quarters > 1 > income Statement > income Tax Expense
137857
Quarters > 1 > income Statement > EBITDA
-2173820
Quarters > 1 > income Statement > operating Margin
-47.90333040816378
Quarters > 1 > income Statement > total Other Income Expense Net
-59434
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
5068021
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1963846
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
7153530
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
18677126
Quarters > 1 > balance Sheet > payables
6202349
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
12737235
Quarters > 1 > balance Sheet > equity
5939891
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-2857887
Quarters > 1 > cash Flow > depreciation
486776
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-2649184
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
25945
Quarters > 1 > cash Flow > cash From Financing
4589297
Quarters > 1 > cash Flow > net Change In Cash
5068021
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.002843667015595155
Quarters > 1 > ratios > PB
0.16919512159398212
Quarters > 1 > ratios > ROE
-48.11345864764185
Quarters > 1 > ratios > ROA
-15.301535150536544
Quarters > 1 > ratios > FCF
-2649184
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.47697860353101695
Quarters > 1 > health Score
20
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
-3512785
Quarters > 2 > income Statement > cost Of Revenue
-482853
Quarters > 2 > income Statement > gross Profit
-3512785
Quarters > 2 > income Statement > operating Expenses
11451238
Quarters > 2 > income Statement > operating Income
-16776080
Quarters > 2 > income Statement > interest Expense
80
Quarters > 2 > income Statement > pretax Income
-23605083
Quarters > 2 > income Statement > net Income
-14973846
Quarters > 2 > income Statement > eps
-0.02199999998824617
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
680629364
Quarters > 2 > income Statement > income Tax Expense
-8631237
Quarters > 2 > income Statement > EBITDA
-13467788
Quarters > 2 > income Statement > operating Margin
477.5720688855139
Quarters > 2 > income Statement > total Other Income Expense Net
-6829003
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3053000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
86588
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3222097
Quarters > 2 > balance Sheet > property Plant Equipment
685
Quarters > 2 > balance Sheet > total Assets
15273154
Quarters > 2 > balance Sheet > payables
3201192
Quarters > 2 > balance Sheet > short Term Debt
3594474
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
12803086
Quarters > 2 > balance Sheet > equity
2470068
Quarters > 2 > balance Sheet > currency_symbol
AUD
Quarters > 2 > cash Flow > net Income
-14973846
Quarters > 2 > cash Flow > depreciation
595288
Quarters > 2 > cash Flow > change In Working Capital
3578655
Quarters > 2 > cash Flow > cash From Operations
-2890472
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-23430
Quarters > 2 > cash Flow > cash From Financing
2396821
Quarters > 2 > cash Flow > net Change In Cash
-472402
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.02199999998824617
Quarters > 2 > ratios > PB
0.2755508609479577
Quarters > 2 > ratios > ROE
-606.2118937616292
Quarters > 2 > ratios > ROA
-98.04029999304662
Quarters > 2 > ratios > FCF
-2890472
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
0.8228434134169896
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
5485222
Quarters > 3 > income Statement > cost Of Revenue
486775
Quarters > 3 > income Statement > gross Profit
10970443
Quarters > 3 > income Statement > operating Expenses
8726503
Quarters > 3 > income Statement > operating Income
2654347
Quarters > 3 > income Statement > interest Expense
331731
Quarters > 3 > income Statement > pretax Income
-3470946
Quarters > 3 > income Statement > net Income
2443997
Quarters > 3 > income Statement > eps
0.0043827139895728
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
557644648
Quarters > 3 > income Statement > income Tax Expense
72951
Quarters > 3 > income Statement > EBITDA
2243940
Quarters > 3 > income Statement > operating Margin
48.39087643125474
Quarters > 3 > income Statement > total Other Income Expense Net
-4349529
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
3525403
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
10521233
Quarters > 3 > balance Sheet > inventories
1
Quarters > 3 > balance Sheet > total Current Assets
14154846
Quarters > 3 > balance Sheet > property Plant Equipment
1492
Quarters > 3 > balance Sheet > total Assets
26688194
Quarters > 3 > balance Sheet > payables
3433509
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
12825310
Quarters > 3 > balance Sheet > equity
13862884
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
2443997
Quarters > 3 > cash Flow > depreciation
486775
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-4657365
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
23430
Quarters > 3 > cash Flow > cash From Financing
5870051
Quarters > 3 > cash Flow > net Change In Cash
-1844251
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.0043827139895728
Quarters > 3 > ratios > PB
0.040225731384609435
Quarters > 3 > ratios > ROE
17.629787568012542
Quarters > 3 > ratios > ROA
9.157596051647406
Quarters > 3 > ratios > FCF
-4657365
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.8490750237638514
Quarters > 3 > health Score
67
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
3968525
Annuals > 0 > income Statement > cost Of Revenue
846763
Annuals > 0 > income Statement > gross Profit
3121762
Annuals > 0 > income Statement > operating Expenses
18233222
Annuals > 0 > income Statement > operating Income
-15111460
Annuals > 0 > income Statement > interest Expense
211032
Annuals > 0 > income Statement > pretax Income
-10319615
Annuals > 0 > income Statement > net Income
-10430424
Annuals > 0 > income Statement > eps
-0.00771524332652682
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1351924179
Annuals > 0 > income Statement > income Tax Expense
110809
Annuals > 0 > income Statement > EBITDA
-9076526
Annuals > 0 > income Statement > operating Margin
-380.78278453581623
Annuals > 0 > income Statement > total Other Income Expense Net
4791845
Annuals > 0 > income Statement > currency_symbol
AUD
Annuals > 0 > balance Sheet > cash
5757474
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4551105
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
10526412
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
21571171
Annuals > 0 > balance Sheet > payables
6566448
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
19596657
Annuals > 0 > balance Sheet > equity
1974514
Annuals > 0 > balance Sheet > currency_symbol
AUD
Annuals > 0 > cash Flow > net Income
-10430424
Annuals > 0 > cash Flow > depreciation
1032057
Annuals > 0 > cash Flow > change In Working Capital
-214176
Annuals > 0 > cash Flow > cash From Operations
-7275729
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
10046000
Annuals > 0 > cash Flow > net Change In Cash
2704473
Annuals > 0 > cash Flow > currency_symbol
AUD
Annuals > 0 > ratios > PE
-0.00771524332652682
Annuals > 0 > ratios > PB
0.6846870566630573
Annuals > 0 > ratios > ROE
-528.2527244678944
Annuals > 0 > ratios > ROA
-48.35353630083411
Annuals > 0 > ratios > FCF
-7275729
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.8333584896151593
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
3922
Annuals > 1 > income Statement > gross Profit
-3922
Annuals > 1 > income Statement > operating Expenses
20715274
Annuals > 1 > income Statement > operating Income
-20719200
Annuals > 1 > income Statement > interest Expense
331811
Annuals > 1 > income Statement > pretax Income
-21234037
Annuals > 1 > income Statement > net Income
-12529849
Annuals > 1 > income Statement > eps
-0.01801198547194682
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
695639524
Annuals > 1 > income Statement > income Tax Expense
-8704188
Annuals > 1 > income Statement > EBITDA
-11223848
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-514837
Annuals > 1 > income Statement > currency_symbol
AUD
Annuals > 1 > balance Sheet > cash
3053000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
86588
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
3222097
Annuals > 1 > balance Sheet > property Plant Equipment
685
Annuals > 1 > balance Sheet > total Assets
15273154
Annuals > 1 > balance Sheet > payables
3201192
Annuals > 1 > balance Sheet > short Term Debt
3594474
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
12803086
Annuals > 1 > balance Sheet > equity
2470068
Annuals > 1 > balance Sheet > currency_symbol
AUD
Annuals > 1 > cash Flow > net Income
-12529849
Annuals > 1 > cash Flow > depreciation
3922
Annuals > 1 > cash Flow > change In Working Capital
3578655
Annuals > 1 > cash Flow > cash From Operations
-7537724
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
8256759
Annuals > 1 > cash Flow > net Change In Cash
690347
Annuals > 1 > cash Flow > currency_symbol
AUD
Annuals > 1 > ratios > PE
-0.01801198547194682
Annuals > 1 > ratios > PB
0.28162768150512457
Annuals > 1 > ratios > ROE
-507.2673707768369
Annuals > 1 > ratios > ROA
-82.03838578462576
Annuals > 1 > ratios > FCF
-7537724
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
24
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
4505729
Annuals > 2 > income Statement > cost Of Revenue
965351
Annuals > 2 > income Statement > gross Profit
4505729
Annuals > 2 > income Statement > operating Expenses
29487199
Annuals > 2 > income Statement > operating Income
-25077790
Annuals > 2 > income Statement > interest Expense
773845
Annuals > 2 > income Statement > pretax Income
-25407564
Annuals > 2 > income Statement > net Income
-25500384
Annuals > 2 > income Statement > eps
-0.05885910068249216
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
433244540
Annuals > 2 > income Statement > income Tax Expense
92820
Annuals > 2 > income Statement > EBITDA
-24016119
Annuals > 2 > income Statement > operating Margin
-556.5756395912848
Annuals > 2 > income Statement > total Other Income Expense Net
-329774
Annuals > 2 > income Statement > currency_symbol
AUD
Annuals > 2 > balance Sheet > cash
2362654
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
6658131
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
9351353
Annuals > 2 > balance Sheet > property Plant Equipment
5600
Annuals > 2 > balance Sheet > total Assets
22375584
Annuals > 2 > balance Sheet > payables
7406782
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
16714868
Annuals > 2 > balance Sheet > equity
5660716
Annuals > 2 > balance Sheet > currency_symbol
AUD
Annuals > 2 > cash Flow > net Income
-25916890
Annuals > 2 > cash Flow > depreciation
965351
Annuals > 2 > cash Flow > change In Working Capital
3847639
Annuals > 2 > cash Flow > cash From Operations
-16316054
Annuals > 2 > cash Flow > capital Expenditures
112193
Annuals > 2 > cash Flow > cash From Investing
-112193
Annuals > 2 > cash Flow > cash From Financing
253376
Annuals > 2 > cash Flow > net Change In Cash
-16018879
Annuals > 2 > cash Flow > currency_symbol
AUD
Annuals > 2 > ratios > PE
-0.05885910068249216
Annuals > 2 > ratios > PB
0.07653528988205732
Annuals > 2 > ratios > ROE
-450.47983329317344
Annuals > 2 > ratios > ROA
-113.96522209208038
Annuals > 2 > ratios > FCF
-16428247
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.646079690988961
Annuals > 2 > health Score
19
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
2617122
Annuals > 3 > income Statement > cost Of Revenue
949762
Annuals > 3 > income Statement > gross Profit
1667360
Annuals > 3 > income Statement > operating Expenses
17189699
Annuals > 3 > income Statement > operating Income
-15092488
Annuals > 3 > income Statement > interest Expense
640127
Annuals > 3 > income Statement > pretax Income
-15734680
Annuals > 3 > income Statement > net Income
-15898400
Annuals > 3 > income Statement > eps
-0.0441705113094529
Annuals > 3 > income Statement > dividends Per Share
4046819
Annuals > 3 > income Statement > shares Outstanding
359932442
Annuals > 3 > income Statement > income Tax Expense
163720
Annuals > 3 > income Statement > EBITDA
-13622815
Annuals > 3 > income Statement > operating Margin
-576.6826307676906
Annuals > 3 > income Statement > total Other Income Expense Net
-627150
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
18381533
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
40573
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
21170711
Annuals > 3 > balance Sheet > property Plant Equipment
15988
Annuals > 3 > balance Sheet > total Assets
34879739
Annuals > 3 > balance Sheet > payables
4703609
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
9173431
Annuals > 3 > balance Sheet > equity
25706308
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-15898400
Annuals > 3 > cash Flow > depreciation
949762
Annuals > 3 > cash Flow > change In Working Capital
-2211619
Annuals > 3 > cash Flow > cash From Operations
-13152891
Annuals > 3 > cash Flow > capital Expenditures
537855
Annuals > 3 > cash Flow > cash From Investing
-564878
Annuals > 3 > cash Flow > cash From Financing
9503678
Annuals > 3 > cash Flow > net Change In Cash
-4028666
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.0441705113094529
Annuals > 3 > ratios > PB
0.014001716699263075
Annuals > 3 > ratios > ROE
-61.846298581655525
Annuals > 3 > ratios > ROA
-45.58061629990981
Annuals > 3 > ratios > FCF
-13690746
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-5.231221930043765
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.004457454692565163
Valuation > metrics > PB
0.8603878108739669
Valuation > final Score
70
Valuation > verdict
14.0% Undervalued
Profitability > metrics > ROE
-383.5139685006032
Profitability > metrics > ROA
-71.938443982622
Profitability > metrics > Net Margin
-1.0619998737807572
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
9.924800229322253
Risk > metrics > Interest Coverage
-72.36285706011256
Risk > final Score
-283
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.603060284647042
Liquidity > metrics > Quick Ratio
1.603060284647042
Liquidity > final Score
90
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
0
Prev Profitabilities > 1
30
Prev Profitabilities > 2
95
Prev Risks > 0
-161
Prev Risks > 1
-838798
Prev Risks > 2
80
Prev Liquidities > 0
79
Prev Liquidities > 1
34
Prev Liquidities > 2
100
Updated At
2026-01-20T21:35:53.288Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Chimeric Therapeutics Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.